drugset / Trial / NCT05609955
Effects Of Additional MgSO4 30 Mg/KgBW Intravenous and Ketorolac
RandomizedParallel-groupSingle-blindTreatment
Summary
This study aims to compare two groups of post-orthopedic patients who received a standard regimen, namely ketorolac 30mg, to the second group, which was given the standard regimen and adjuvant magnesium sulfate 30mg/kgBW 1 hour preoperatively. If it is proven useful, it is hoped that pain will be more controlled, reduce pain complications, reduce treatment costs, and reduce the duration of hospital stays.
Timeline
- Start
- 2022-01-01
- Primary completion
- 2022-10-01
- Completion
- 2022-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Sulfate | Other / unclassified | 30 mg/kg | Intravenous |